Biotechnology · Healthcare
Board Member
Since 2022-01-01, last confirmed 2024-04-29
Equibles does not estimate personal net worth.
Mary Ann Gray was last confirmed as Board Member at Compass Therapeutics, Inc. (CMPX) in a filing dated April 29, 2024. Compass Therapeutics, Inc. reported in an 8-K filed April 26, 2022 that Mary Ann Gray was appointed director, effective April 25, 2022.
“On April 25, 2022, the Board of Directors (the “Board”) of Compass Therapeutics, Inc. (the “Company”) appointed two new directors to its Board: Ellen Chiniara, J.D., former Chief Legal Officer of Alexion Pharmaceuticals; and Mary Ann Gray, Ph.D., President of Gray Strategic Advisors.”
2022-01-01–2024-04-29
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
Board Member
Since 2022-01-01, last confirmed 2024-04-29